AbhishekKumarMD

Radiation Oncology Resident (Duke 2021-2025) Preliminary Medicine Resident (UC San Diego 2020-2021)

Dr. Kumar is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

I am a radiation oncology resident physician passionate about improving patients' quality and quantity of life. I hope to contribute to innovating cancer care with cost-effective technologies everyone has access to. I also want to find ways to implement digital solutions to improve patient education and decrease administrative burden in health care.

My research interests include cost-effectiveness in oncology, the validity of using observational big data for comparative effectiveness, oncologic outcomes of Veterans, and health disparities.

Duke University HospitalResidency, Radiation Oncology, 2021 - 2025
University of California (San Diego) Medical CenterInternship, Preliminary Year, 2020 - 2021
University of California San Diego School of MedicineClass of 2020, MD
University of California San Diego School of MedicineMAS, Clinical Research, 2018 - 2019
Duke UniversityBSE, Biomedical Engineering, 2006 - 2011

Genitourinary Cancers Symposium Merit Award for "Association of multiparametric MRI findings on Oncologic Outcomes in Non-Palpable Localized Prostate Cancer" American Society of Clinical Oncology (ASCO), 2024
Genitourinary Cancers Symposium Merit Award for "Utilization of local treatment modalities and surveillance in veterans with early stage renal cell carcinoma" American Society of Clinical Oncology (ASCO), 2023
High scored abstract, "Impact of Operability Bias on Outcomes in Veterans with Muscle Invasive Bladder Cancer Receiving Trimodality Therapy" American College of Radiation Oncology (ACRO), 2023
Genitourinary Cancers Symposium Merit Award for "Impact of selection bias on outcomes in veterans with muscle invasive bladder cancer receiving bladder preserving trimodality therapy" American Society of Clinical Oncology (ASCO), 2022
30-Under-30 (Education) Forbes, 2019
Join now to see all

PubMed